Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17212329 | 1.00 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL6904892 | 1.00 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL3815253 | 1.00 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL7879521 | 0.97 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL9355818 | 0.94 | DGKA (0.59) | DGKAMEN1KMT2APAMALDH1A1 | |
| SCHEMBL4340206 | 0.90 | DGKA (0.62) | DGKAMAPTDNM1LMNAMEN1 | |
| SCHEMBL3487129 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL294266 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL3487063 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL3813041 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8795547-B2 | Refrigeration oil from gas-to-liquid-derived and bio-derived triesters | CHEVRON U.S.A. INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-20130256586-A1 | REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED TRIESTERS | CHEVRON U.S.A., INC. | 2013-10-03 | — | — | US | disclosed |
| WO-2013048606-A2 | INDUSTRIAL OIL COMPRISING A BIO-DERIVED ESTER | CHEVRON U.S.A. INC. (US) | 2013-04-04 | — | — | WO | disclosed |
| US-20130085091-A1 | INDUSTRIAL OIL COMPRISING A BIO-DERIVED ESTER | CHEVRON U.S.A. INC. (US) | 2013-04-04 | — | — | US | disclosed |
| EP-2227529-A2 | REFRIGERATION OIL FROM GAS-TO-LIQUID DERIVED AND BIO-DERIVED TRIESTERS | Chevron U.S.A. Inc. (US) | 2010-09-15 | — | — | EP | disclosed |
| EP-2132283-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | Chevron U.S.A., Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| WO-2009085855-A2 | REFRIGERATION OIL FROM GAS-TO-LIQUID DERIVED AND BIO-DERIVED TRIESTERS | CHEVRON U.S.A. INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| US-20090159835-A1 | REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED TRIESTERS | CHEVRON U.S.A., INC. | 2009-06-25 | — | — | US | disclosed |
| US-7544645-B2 | Triester-based lubricants and methods of making same | CHEVRON U.S.A. INC. (US) | 2009-06-09 | — | — | US | disclosed |
| WO-2008124294-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | CHEVRON U.S.A. INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| US-20080248982-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | CHEVRON U.S.A. INC. (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248982-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | ADH5, ADH1A, ELOVL5 | DGKA 165/4885MAPT 2206/4885PRSS1 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.